-+ 0.00%
-+ 0.00%
-+ 0.00%

10x Genomics Collaborates With Charité And Seoul National University On Identifying Blood-Based Biomarkers Of Disease Activity And Treatment Response For Autoimmune Disease

Benzinga·11/16/2026 21:22:01
Listen to the news

Collaborations with Charité and DRFZ, and with Seoul National University, aim to identify biomarkers of disease activity and treatment response using 10x's Flex Apex platform

PLEASANTON, Calif., Nov. 16, 2026 /PRNewswire/ -- 10x Genomics, Inc. (NASDAQ:TXG), the life science technology leader focused on accelerating science and advancing human health, today announced two new research collaborations focused on identifying blood-based biomarkers of disease activity and treatment response for autoimmune disease. The first collaboration is with Charité – Universitätsmedizin Berlin, one of Europe's largest university hospitals, and the German Rheumatology Research Center Berlin (DRFZ). The second is with the Genomic Medicine Institute at Seoul National University (SNU), one of South Korea's leading research universities.